FDA – MicroVibeNews

Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy

Spero Therapeuti…

Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds

Legend Biotech: …

Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again

Third Time'…

Feel Free customers say the kratom drink is making them sick—so why is it still a bestseller?

For two decades,…

Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript

Agios Pharmaceut…

Agios Pharma Stock: A Buy After FDA Approves Aqvesme (NASDAQ:AGIO)

This article was…

Female libido pill gets expanded approval for menopause by FDA

U.S. health offi…